Functional Genetic Biomarkers of Alzheimer's Disease and Gene Expression from Peripheral Blood
ISEF · 2020 Computational Biology and Bioinformatics
Overview
Detecting Alzheimer’s Disease (AD) at the earliest possible stage is key in advancing AD prevention and treatment but is challenged by confounders with the normal aging processes in addition to other neurodegenerative diseases. Recent genome-wide association studies (GWAS) have identified associated alleles, but it has been difficult to transition from non-coding genetic variants to underlying mechanisms of AD. We sought to reveal functional genetic variants and diagnostic biomarkers underlying AD using machine learning techniques. We first developed a Random Forest (RF) classifier using blood microarray gene expression data from 744 participants in Alzheimer’s Disease Neuroimaging Initiative cohort. After initial feature selection, 5-fold cross-validation of the 100-gene RF classifier achieved an accuracy of 98.4%. The high accuracy of the RF classifier supports the possibility of a powerful and minimally invasive tool for screening of AD. Then, unsupervised clustering was used to identify relationships among differentially expressed genes (DEGs) the RF selected. Results suggest downregulation of global sulfatase and oxidoreductase activities in AD through mutations in SUMF1 and SMOX respectively. Finally, we used Greedy Fast Causal Inference (GFCI) to find potential causes of AD within DEGs. In the causal graph, HLA-DPB1 emerges as the largest node. HLA-DPB1 is downregulated and indirectly causes AD, validated by its mechanisms in the immune system which lead to increased neuron death and the progression of neurodegenerative disorders through its role in T-cell receptors and antibody/antigen production. This study further advances understanding of molecular mechanisms underlying AD and provides potential gene targets for further experimentation.
Competition history
- ISEF 2020
Resources
Related projects
ISEF · 2022
A Machine Learning Approach to Identifying Blood-Based Biomarkers for Differential Diagnosis of Alzheimer's Disease
ISEF · 2024
A Blood-Based Transcriptomic Algorithm and Scoring System for Alzheimer's Disease Detection
ISEF · 2025
Novel Differentially Expressed Genes in Alzheimer's Disease, LATE, and Their Co-Occurrence
ISEF · 2025
Non-Invasive Blood-Based Early Alzheimer's Detection Using Sex-Specific Brain-Blood Graph Reinforcement Learning
ISEF · 2023
Identification of Cell-Free DNA Methylation Signatures as a Potential Genomic Biomarker of Alzheimer's Disease
ISEF · 2024
Novel Drug Discovery Methodology Using Machine Learning for Gene Expression-Based Virtual Screening Predicts Novel Compounds To Reverse Alzheimer's Disease With Applications to Cancer and Longevity by Inhibiting CtBP2 Expression
ISEF · 2024
Identification of Novel Target Genes and ML-Based Drug Repurposing and Discovery for Alzheimer’s Disease in the Presence of Metabolic Comorbidities
ISEF · 2022
Associations of Genetic SNPs With AD, Neuropathology, and Gene Expression Offers Novel Insight Into AD
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: Regeneron International Science and Engineering Fair